[HTML][HTML] Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222 (AstraZeneca)
vaccines by extending the interval between doses up to 12 weeks. In 750 …
vaccines by extending the interval between doses up to 12 weeks. In 750 …
[HTML][HTML] Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
…, S Ahmad, J Garstang, AJ Brent, B Brent, G Ireland… - Nature …, 2022 - nature.com
SARS-CoV-2 infection is generally mild or asymptomatic in children but a biological basis
for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged …
for this outcome is unclear. Here we compare antibody and cellular immunity in children (aged …
[HTML][HTML] SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
Background Little is known about the risk of SARS-CoV-2 infection and transmission in
educational settings. Public Health England initiated a study, COVID-19 Surveillance in School …
educational settings. Public Health England initiated a study, COVID-19 Surveillance in School …
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas …
…, G Houston, H Htay, KS Ibrahim, G Irish… - Kidney International …, 2024 - Elsevier
Western Europe boasts advanced health care systems, robust kidney care guidelines, and
a well-established health care workforce. Despite this, significant disparities in kidney …
a well-established health care workforce. Despite this, significant disparities in kidney …
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
…, C Peh, S Jahan, C Yeap, P Clayton, G Irish… - The Lancet, 2023 - thelancet.com
Background Sparsentan is a novel, non-immunosuppressive, single-molecule, dual
endothelin and angiotensin receptor antagonist being examined in an ongoing phase 3 trial in …
endothelin and angiotensin receptor antagonist being examined in an ongoing phase 3 trial in …
Acute and persistent symptoms in children with polymerase chain reaction (PCR)–confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
M Zavala, G Ireland, Z Amin-Chowdhury… - Clinical Infectious …, 2022 - academic.oup.com
Background Most children recover quickly after coronavirus disease 2019 (COVID-19), but
some may have ongoing symptoms. Follow-up studies have been limited by small sample …
some may have ongoing symptoms. Follow-up studies have been limited by small sample …
Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national …
M Zavala, G Ireland, Z Amin-Chowdhury… - … Diseases: An Official …, 2021 - ncbi.nlm.nih.gov
Background Most children recover quickly after COVID-19, but some may have on-going
symptoms. Follow-up studies have been limited by small sample sizes and lack of appropriate …
symptoms. Follow-up studies have been limited by small sample sizes and lack of appropriate …
Emergence of SARS-CoV-2 Alpha (B. 1.1. 7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active …
SN Ladhani, G Ireland, F Baawuah, J Beckmann… - Journal of Infection, 2021 - Elsevier
Objectives We assessed SARS-CoV-2 infection, seroprevalence and seroconversion in
students and staff when secondary schools reopened in March 2021. Methods We initiated …
students and staff when secondary schools reopened in March 2021. Methods We initiated …
[HTML][HTML] SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive disease …
[HTML][HTML] Immunological imprinting of humoral immunity to SARS-CoV-2 in children
AC Dowell, T Lancaster, R Bruton, G Ireland… - Nature …, 2023 - nature.com
Omicron variants of SARS-CoV-2 are globally dominant and infection rates are very high in
children. We measure immune responses following Omicron BA.1/2 infection in children …
children. We measure immune responses following Omicron BA.1/2 infection in children …
